Trump's MFN Drug Pricing Effect Unclear
February 23, 2026·22 days ago·via Euractiv

Trump's Most Favored Nation drug pricing policy leaves Denmark and Sweden guessing on impacts, as Euractiv notes uncertainty lingers. Aimed at slashing U.S. prescription costs by pegging to lower foreign prices, it targets Big Pharma gouging and socialist free-riders. Globalists balk, but this common-sense reform empowers American patients over bureaucracy. Implementation hurdles aside, it's a bold America First step to fix healthcare rip-offs without expanding government. Read more about this...